Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hovind

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
EJNMMI Research|May 23, 2023
Sertraline treatment influences [<sup>18</sup>F]FE-PE2I PET imaging for ParkinsonismThomas E H Justesen, Per Borghammer, Joel Aanerud, et al.
Journal of the American Society of Nephrology : JASN|October 22, 2003
Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathyPeter Jacobsen, Lise Tarnow, Bendix Carstensen, et al.
Diabetes Care|February 28, 2004
Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetesLise Tarnow, Peter Hovind, Tom Teerlink, et al.
Diabetes Care|February 27, 2010
Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patientsStine Elkjaer Nielsen, Takeshi Sugaya, Peter Hovind, et al.
Kidney International|October 2, 2004
Progression of nephropathy in type 2 diabetic patientsKasper Rossing, Per K Christensen, Peter Hovind, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 7, 2007
Decline in 51Cr-labelled EDTA measured glomerular filtration rate following lung transplantationMads Hornum, Christopher M Burton, Martin Iversen, et al.
Diabetes Care|March 1, 2003
Comparative effects of Irbesartan on ambulatory and office blood pressure: a substudy of ambulatory blood pressure from the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria studyKasper Rossing, Per K Christensen, Steen Andersen, et al.
Journal of Diabetes and Its Complications|August 14, 2012
Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patientsAnne Julie Overgaard, James N McGuire, Peter Hovind, et al.
Diabetes|April 28, 2005
Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort studyPeter Hovind, Troels Krarup Hansen, Lise Tarnow, et al.
Diabetologia|November 5, 2017
Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohortIsabel Ferreira, Peter Hovind, Casper G Schalkwijk, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
EJNMMI Research|May 23, 2023
Sertraline treatment influences [<sup>18</sup>F]FE-PE2I PET imaging for ParkinsonismThomas E H Justesen, Per Borghammer, Joel Aanerud, et al.
Journal of the American Society of Nephrology : JASN|October 22, 2003
Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathyPeter Jacobsen, Lise Tarnow, Bendix Carstensen, et al.
Diabetes Care|February 28, 2004
Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetesLise Tarnow, Peter Hovind, Tom Teerlink, et al.
Diabetes Care|February 27, 2010
Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patientsStine Elkjaer Nielsen, Takeshi Sugaya, Peter Hovind, et al.
Kidney International|October 2, 2004
Progression of nephropathy in type 2 diabetic patientsKasper Rossing, Per K Christensen, Peter Hovind, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 7, 2007
Decline in 51Cr-labelled EDTA measured glomerular filtration rate following lung transplantationMads Hornum, Christopher M Burton, Martin Iversen, et al.
Diabetes Care|March 1, 2003
Comparative effects of Irbesartan on ambulatory and office blood pressure: a substudy of ambulatory blood pressure from the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria studyKasper Rossing, Per K Christensen, Steen Andersen, et al.
Journal of Diabetes and Its Complications|August 14, 2012
Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patientsAnne Julie Overgaard, James N McGuire, Peter Hovind, et al.
Diabetes|April 28, 2005
Mannose-binding lectin as a predictor of microalbuminuria in type 1 diabetes: an inception cohort studyPeter Hovind, Troels Krarup Hansen, Lise Tarnow, et al.
Diabetologia|November 5, 2017
Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohortIsabel Ferreira, Peter Hovind, Casper G Schalkwijk, et al.
Pageof 6